During a second quarter earnings call with analysts, Pfizer CEO Ian Read took a cautious tone when talking about a potential splitting up of the ...
via
During a second quarter earnings call with analysts, Pfizer CEO Ian Read took a cautious tone when talking about a potential splitting up of the ...
via